Green Chemicals Blog
synthetic biology
DuPont bags grant for biologic medications
This might not be targeting industrial applications but then the use of biotechnology has constantly been crossing over between pharma/life science, industrial chemicals, biofuels, and consumer/nutritional products. DuPont Industrial Biosciences recently announced receipt of a grant from the Bill & Melinda Gates Foundation to support a new area of research. The research project, which commences immediately, … Continue reading
Amyris, Ginkgo Bioworks iron out collaboration deal
Amyris, Inc. has completed a subsequent collaboration agreement with Ginkgo Bioworks which finalizes details of how the two companies will jointly develop cultured products more efficiently and cost effectively, accelerating time to market for bio-based products. The collaboration was initially announced on June 29, 2016. Per the agreement, Ginkgo and Amyris will share in the … Continue reading
Synthetic Biology – The next renewables frontier?
Ok, so the title might be a bit misleading as I’ve been covering agbiotech for more than a decade and synthetic biology companies focusing on chemicals application since 2007 such as Genomatica, Amyris, Codexis, etc. However, it seems there are more and more interests these days on genome engineering tools for chemicals production as DNA synthesis … Continue reading
North Face develops coat from biotech silk
Coming from the recent SynBioBeta conference, I may not be able to understand some of the technicalities of gene modification but I do understand the potential economics on some of these technologies being churned out of the lab. One of them is biotech spider silk that the blog mentioned in September, where California-based Bolt Threads … Continue reading
Spotlight: Imperial College London Bio activities
The blog had the pleasure of speaking with Imperial College London’s Professor Richard Ian Kitney (Chairman of Institute of Systems & Synthetic Biology as well as Co-director EPSRC Centre for Synthetic Biology and Innovation) at the recent SynBioBeta conference in San Francisco. While the blog is not that much familiar with the synthetic biology industry, … Continue reading
DuPont starts cellulosic ethanol plant
Happy November blog readers! I am 10,000 feet in the air enjoying the gogowifi at Delta on my way to San Francisco to cover this week’s SynBioBeta conference. Follow my tweets at @DGreenblogger #SBBSF15. Meanwhile, the biofuel industry (and renewable chemicals as well) was abuzz with the recent opening of DuPont’s much anticipated Nevada, Iowa, … Continue reading
Codexis sells Budapest lab to Intrexon
Synthetic biology company, Intrexon Corporation, has acquired state-of-the-art laboratory operations in Budapest, Hungary from biocatalysts developer Codexis, Inc. The acquisition will expand Intrexon’s strain and protein development capabilities, as well as strengthen fermentation process optimization and scale-up. Intrexon’s Industrial Products Division (IPD) will absorb the Budapest laboratory staff. Intrexon’s IPD is positioned to develop biologically based solutions … Continue reading